Abstract
Purpose.
To elucidate whether hK2 mRNA can be detected in peripheral blood of patients with thyroid disease using reverse transcription polymerase chain reaction (RT-PCR).
Methods.
A nested RT-PCR protocol for the detection of hK2 mRNA was established, and blood samples of 72 patients with a history of thyroid cancer, 10 patients with current metastases of thyroid cancer, and 32 volunteers were tested.
Results.
hK2-transcripts were significantly more often detected in patients with thyroid cancer (20/72=28%) than in the control group (2/32=6%, P = 0.03, chi-square analysis).
Conclusions.
This is the first study reporting on hK2 as a potential molecular marker for patients with thyroid cancer. We could demonstrate a correlation between diagnosis of thyroid cancer and the positive signal for hK2 in the RT-PCR assay. Future studies are necessary to prove the clinical value of hK2 as a molecular marker regarding recurrence and outcome.
Similar content being viewed by others
References
Arturi F, Russo D, Giuffrida D, Ippolito A, Perrotti N, Vigneri R, Filetti S (1997) Early diagnosis by genetic analysis of differentiated thyroid cancer metastasis in small lymph nodes. J Clin Endocrinol Metab 82:1638–1641
Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14:146
Aust G, Crisp M, Bosenberg E, Ludgate M, Weetman AP, Paschke R (1998) Transcription of thyroid autoantigens in non-expressing tissues. Exp Clin Endocrinol Diabetes. 106:319–323
Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, Maussier L, Salvatori M, Rufini V, Reale F, Romano L, Tallini G, Zelano G, Pontecorvi A (2001) Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer 92:2273–2279
Biscolla RP, Cerutti JM, Maciel RM (2000) Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85:3623–3627
Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJ, Tindall DJ, Young CY, Sauter ER, Diamandis EP (2000) Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Br J Cancer 82:361–367
Bojunga J, Roddiger S, Stanisch M, Kusterer K, Kurek R, Renneberg H, Adams S, Lindhorst E, Usadel KH, Schumm-Draeger PM (2000) Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR. Br J Cancer 82:1650–1655
Brabant G, Maenhaut C, Kohrle J, Scheumann G, Dralle H, Hoang-Vu C, Hesch RD, von zur Muhlen A, Vassart G, Dumont JE (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–12
Corey E, Corey J (1998) Detection of disseminated prostate cells by reverse transcription polymerase chain reaction (RT-PCR): technical and clinical aspects. Int J Cancer 77:655–673
Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vesella RL (1997) Detection of circulating prostate cells by reverse trancriptase polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology 50:184–188
Curry BJ, Myers K, Hersey P (1998) Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment and recurrence from melanoma. J Clin Oncol 16:1760–1769
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475–482
DeMicco C, Kopp F, Vassko V, Grino M (2000) In situ hybridisation and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors. Thyroid 10:109–115
Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Lo Gerfo PL (1996) Detection of circulating thyroid cells in peripheral blood. Surgery 120:959–965
Fenton C, Anderson JS, Patel AD, Lukes Y, Solomon B, Tuttle RM, Ringel MD, Francis GL (2001) Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease. Pediatr Res 49:429–434
Ghossein RA, Rosai J (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10–16
Ghossein RA, Carusone L, Bhattacharya S (1999) Polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate and thyroid carcinomas. Diagn Mol Pathol 8:165–175
Haber RS (1998) The diagnosis of recurrent thyroid cancer- a new approach. J Clin Endo Metab 83:4189–4199
Kawakami M, Okaneya T, Furihata K, Nishizawa O, Katsuyama E (1997) Detection of prostate cancer cells circulating in peripheral blood by reverse transcriptase polymerase chain reaction. Cancer Res 57:4167–4170
Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K (1995) Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 75:2214–2219
Kurek R, Renneberg H, Konrad L,Wennemuth G, Kiani S, Martin T, Aumüller G, Tunn UW (1998) RT-PCR based detection of circulating cancer cells in peripheral blood of prostate cancer patients: expression of PSA, hK2 and PSM in different human tissues—implications for the use as a diagnostic tool. Eur Urol 34 [Suppl]:261–262
Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD (1997) Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888–896
Lazar V, Bidart JM, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M (1999) Expression of the Na symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228–34
Ligabue A, Poggioli MC, Zacchini (1993) A Interference of specific autoantibodies in the assessment of serum thyroglobulin. J Nucl Biol Med 37:273–279
Magklara A, Cheung CC, Asa SL, Diamandis EP (2000) Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland. Clin Chim Acta 300:171–180
Morris BJ (1989) hGK1: A kallikrein gene expressed in human prostate. Clin Exp Pharmacol Physiol 16:345–351
Riegman PH, Vliestra RJ, Suurmeijer L, Cleutjens CB, Trapman J (1992) Characterisation of the human kallikrein locus. Genomics 14:6–11
Ringel MD, Ladenson PW, Levine MA (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid and peripheral blood. J Clin Endocrinol Metab 1998:4435–4442
Rittenhouse HG, Finlay JA, Mikolajczyk SD, Partin AW (1998) Human kallikrein 2 (hK2) and prostate-specific-antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci 35:275–368
Roddiger SJ, Bojunga J, Klee V, Stanisch M, Renneberg H, Lindhorst E, Usadel KH, Kusterer K, Schumm-Draeger PM, Kurek R (2002) Detection of thyroid peroxidase mRNA in peripheral blood of patients with maliganant and benign thyroid diseases. J Mol Endocrinol 29 (in press)
Savanger F, Rodien P, Reynier P, Rohmer V, Birgorgne JC, Malthiery Y (2002) Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid patients. J Clin Endocrinol Metab 87:635–639
Schedlich LJ, Bennets BH, Morris BJ (1987) Primary structure of a human glandular kallikrein gene. DNA 6:429–437
Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T (1987) Papillary and follicular thyroid cancer—prognostic factors in 1,578 patients. Am J Med 83:479–488
Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N (2001) Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer 85:102–106
Tallini G, Ghossein R. A, Emanuel J, Gill J, Kinder B, Dimich AB Costa J, Robbins R, Burrow GN, Rosai J (1998) Detection of thyroglobulin, thyroid peroxidase and ret/ptc1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16:1158–1166
Wasserman L, Dreilinger A, Easter D, Wallace A (1999) A seminested RT-PCR assay for her2/neu: initial validation of a new method for the detection of disseminated breast cancer. Mol Diagn 4:21–28
Wingo ST, Ringel MD, Anderson JS (1999) Quantitative reverse transcription-PCR measurements of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 45:785–789
Acknowledgments.
The authors are grateful to Simone Kräutlein and Carmen Knörnschild for their excellent technical assistance and to doctors and technicians of the Clinic for Nuclear Medicine, Offenbach for their help in collecting blood samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roddiger, S.J., Renneberg, H., Martin, T. et al. Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer. J Cancer Res Clin Oncol 129, 29–34 (2003). https://doi.org/10.1007/s00432-002-0401-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-002-0401-y